Neuropeptide y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease

Angiology

Volumn 64, Issue 1, 2013, Pages 40-45

  Masoudi Kazemabad, Ali ^a   Jamialahmadi, Khadijeh ^b   Moohebati, Mohsen ^c   Mojarrad, Majid ^b   Manshadi, Raheleh Dehghan ^b   Akhlaghi, Saeed ^b   Ferns, Gordon A ^d   Ghayour Mobarhan, Majid ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Leu7pro polymorphism; metabolic syndrome; neuropeptide Y; PCR RFLP

Indexed keywords

NEUROPEPTIDE Y DERIVATIVE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NPY GENE; OBESITY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPEPTIDE Y; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84870951390     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711435149     Document Type: Article

References (26)

1. Lakka HM, Laaksonen DE, Lakka TA. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002 ; 288 (21). 2709-2716 (Pubitemid 35403784)
2. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord. 2007 ; 7 (30). 32
3. Azimi-Nezhad M, Ghayour-Mobarhan M, Safarian M. Anthropometric indices of obesity and the prediction of cardiovascular risk factors in an Iranian population. Sci World J. 2009 ; 9 (12). 424-430
4. Mirhosseini NZ, Yusoff NA, Shahar S, Parizadeh SM, Mobarhen MG, Shakery MT. Prevalence of the metabolic syndrome and its influencing factors among adolescent girls in Mashhad, Iran. Asia Pac J Clin Nutr. 2009 ; 18 (1). 131-136
5. Kelishadi R, Gharipour M, Sadri GH, Tavasoli AA, Amani A. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population. East Mediterr Health J. 2008 ; 14 (5). 1070-1079
6. Sarrafzadegan N, Kelishadi R, Baghaei A. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan healthy heart program. Int J Cardiol. 2008 ; 131 (1). 90-96
7. Athyros VG GE, Tziomalos K, Papageorgiou AA. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010 ; 26 (3). 713-719
8. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS. Control of feeding and sexual behaviors by neuropeptide Y: physiological implications. Synapse. 1988 ; 2 (3). 254-257
9. Kalra SP, Dube MG, Kalra PS. Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin. Peptides. 1988 ; 9 (4). 723-728 (Pubitemid 19268169)
10. Ueno H, Yamaguchi H, Mizuta M, Nakazato M. The role of PYY in feeding regulation. Regul Pept. 2008 ; 145 (1-3). 12-16
11. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 1984 ; 115 (1). 427-429 (Pubitemid 14086844)
12. Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Hemodynamic consequences of neuropeptide Y-induced obesity. Am J Hypertens. 2002 ; 15 (2 pt 1). 137-142 (Pubitemid 34161088)
13. Lin EJ, Sainsbury A, Lee NJ. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology. 2006 ; 147 (11). 5094-5101 (Pubitemid 44790561)
14. Bhaskar LV, Thangaraj K, Non AL. Neuropeptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population. J Hum Hypertens. 2010 ; 24 (9). 617-622
15. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A. 1985 ; 82 (11). 3940-3943 (Pubitemid 15246469)
16. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol. 1991 ; 260 (2 pt 2). R321 - R327
17. Moltz JH, McDonald JK. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides. 1985 ; 6 (6). 1155-1159 (Pubitemid 16166869)
18. Erkkila AT, Lindi V, Lehto S, Laakso M, Uusitupa MI. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Mol Genet Metab. 2002 ; 75 (3). 260-264 (Pubitemid 34971596)
19. Karvonen MK, Pesonen U, Koulu M. Association of a leucine(7)-to- proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med. 1998 ; 4 (12). 1434-1437 (Pubitemid 28553469)
20. Ding B, Kull B, Liu Z. Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept. 2005 ; 127 (1-3). 45-53 (Pubitemid 40179241)
21. Mitchell GC, Wang Q, Ramamoorthy P, Whim MD. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci. 2008 ; 28 (53). 14428-14434
22. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet. 2005 ; 366 (9491). 1059-1062
23. Ghayour-Mobarhan M, Sahebkar A, Parizadeh SM. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol. 2008 ; 89 (3). 209-215 (Pubitemid 351661567)
24. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr. 2010 ; 29 (3 suppl). 289S - 301S
25. Nordman S, Ding B, Ostenson CG. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diabetes. 2005 ; 113 (5). 282-287 (Pubitemid 40868184)
26. Ma J, Nordman S, Mollsten A. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations. Eur J Endocrinol. 2007 ; 157 (5). 641-645 (Pubitemid 350187381)